NF-kB inhibitor PTL may be an agent which can effective against pancreatic cancer, because they can effectively inhibit cell proliferation, induce cell apoptosis and suppress metastatic activity. This evidence concerns the gene NFKB1 and familial pancreatic carcinoma.